Page 3,888«..1020..3,8873,8883,8893,890..3,9003,910..»

Medicine Cardiology Topic 11 Arrythmias Part 01 – Video

Posted: Published on July 22nd, 2014

Medicine Cardiology Topic 11 Arrythmias Part 01 By: Murali Bharadwaz … Continue reading

Posted in Cardiology | Comments Off on Medicine Cardiology Topic 11 Arrythmias Part 01 – Video

Dr. Nanette K. Wenger to Deliver Opening Lecture at International Academy of Cardiology, Annual Scientific Sessions …

Posted: Published on July 22nd, 2014

Beverly Hills, CA (PRWEB) July 22, 2014 Asher Kimchi, M.D., Founder and Chairman of the International Academy of Cardiology, today announced that Nanette K. Wenger, M.D., Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine, Atlanta, Georgia, USA, will deliver the eighth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2014, 19th World Congress on Heart Disease, that will be held in Boston, MA, USA, from Friday, July 25 through Monday, July 28, 2014. Dr. Wengers presentation, Gender Disparity in Coronary Heart Disease: Bias, Biology, or Both? will provide an overview of current understanding of this challenging clinical problem. Cardiovascular disease remains a major cause of mortality for women both in industrialized economies and in developing nations. A stunning improvement has occurred in cardiovascular disease mortality for U.S. women between 2000 and 2010, attributable both to application of evidence-based therapies of established cardiovascular disease and to preventive interventions; these likely derived from research studies of cardiovascular disease in women. Despite these salutatory findings, women remain underrepresented in clinical trials of cardiovascular disease and cardiovascular therapies resulting in substantial gender disparities in preventive interventions, diagnostic procedures, … Continue reading

Posted in Cardiology | Comments Off on Dr. Nanette K. Wenger to Deliver Opening Lecture at International Academy of Cardiology, Annual Scientific Sessions …

Dr David Ackerley talks biotechnology and cancer therapy – Video

Posted: Published on July 22nd, 2014

Dr David Ackerley talks biotechnology and cancer therapy Dr David Ackerley from the School of Biological Sciences, ranked top in New Zealand for research quality, talks about his research in the field of biotechnology and cancer therapy. By: Victoria University of Wellington … Continue reading

Posted in Biotechnology | Comments Off on Dr David Ackerley talks biotechnology and cancer therapy – Video

Lab Testing Equipment by Allied Biotechnology India Pvt. Ltd., Mumbai – Video

Posted: Published on July 22nd, 2014

Lab Testing Equipment by Allied Biotechnology India Pvt. Ltd., Mumbai Welcome to Allied Biotechnology India Pvt. Ltd., was founded in the year 2008 and initiated supplying, distributing and importing of Lab Testing Equipment. The complete business procedure is... By: IndiaMART … Continue reading

Posted in Biotechnology | Comments Off on Lab Testing Equipment by Allied Biotechnology India Pvt. Ltd., Mumbai – Video

DGAP-News: MagForce AG: MagForce Expands into the U.S. Market

Posted: Published on July 22nd, 2014

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA MagForce Expands into the U.S. Market Successful 1st closing of a growth financing round for Magforce USA, Inc. under the lead of Mithril Capital Management Berlin, Germany, July 22, 2014 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that it has successfully established MagForce USA, Inc., together with the grant of a license for the development and commercialization of NanoTherm(TM) Therapy especially for the treatment of brain and prostate cancers. The subsidiary MagForce USA, Inc. will be responsible for developing the North American market (US, Mexico and Canada) for MagForce's technology and products. In the U.S. alone, over USD 10 billion are spent yearly treating prostate cancer. MagForce aims at developing its technology to offer a new focal treatment for Intermediate Stage Prostate Cancer with precise ablation of the cancer lesion while sparing normal tissue. Based on European experience for brain and early prostate cancer trials, the side effects should be minimal. As previously announced, MagForce USA, Inc. has had a positive pre-submission meeting with the FDA. In order to fund MagForce … Continue reading

Comments Off on DGAP-News: MagForce AG: MagForce Expands into the U.S. Market

Puma Biotechnology Soars on Breast Cancer Drug Results

Posted: Published on July 22nd, 2014

Puma Biotechnology Inc. (PBYI) almost tripled in extended trading after the company said a clinical trial of its experimental drug blocked the return of breast cancer in women with a type of early-stage disease. The drug, neratinib, improved disease-free survival by 33 percent compared with a placebo in a trial of 2,821 women with early-stage HER2-positive breast cancer, Los Angeles-based Puma said today in a statement. Disease-free survival refers to the interval a patient remains alive and free of signs of the illness. The company said it would apply for U.S. regulatory approval in the first half of 2015 based on the results. We are very pleased with the results, Alan Auerbach, Pumas chief executive officer, said in the statement. The company didnt return a call seeking further comment. Puma almost tripled to $169.48 in extended trading at 5:35 p.m. New York time after closing at $59.03. The company had declined 43 percent this year. If the drug is approved, neratinib may be used in many early-stage breast cancer patients whose tumors are fueled by a growth promoting gene called HER2. These patients are already often treated with the Roche Holding AG (ROG)s Herceptin. In the new trial, neratinib was … Continue reading

Posted in Biotechnology | Comments Off on Puma Biotechnology Soars on Breast Cancer Drug Results

Dr Nicky Nelson talks conservation biology – Video

Posted: Published on July 22nd, 2014

Dr Nicky Nelson talks conservation biology Dr Nicky Nelson from the School of Biological Sciences, ranked top in New Zealand for research quality, talks about her research in the field of conservation biology. By: Victoria University of Wellington … Continue reading

Posted in Biology | Comments Off on Dr Nicky Nelson talks conservation biology – Video

Marmoset Genome Sequence Sheds Light On Primate Biology And Evolution

Posted: Published on July 22nd, 2014

July 22, 2014 Glenna Picton, Baylor College of Medicine A team of scientists from around the world led by Baylor College of Medicine and Washington University in St. Louis has completed the genome sequence of the common marmoset the first sequence of a New World Monkey providing new information about the marmosets unique rapid reproductive system, physiology and growth, shedding new light on primate biology and evolution. The team published the work today in the journal Nature Genetics. We study primate genomes to get a better understanding of the biology of the species that are most closely related to humans, said Dr. Jeffrey Rogers, associate professor in the Human Genome Sequencing Center at Baylor and a lead author on the report. The previous sequences of the great apes and macaques, which are very closely related to humans on the primate evolutionary tree, have provided remarkable new information about the evolutionary origins of the human genome and the processes involved. With the sequence of the marmoset, the team revealed for the first time the genome of a non-human primate in the New World monkeys, which represents a separate branch in the primate evolutionary tree that is more distant from humans than … Continue reading

Posted in Biology | Comments Off on Marmoset Genome Sequence Sheds Light On Primate Biology And Evolution

Biology is a hard problem [Pharyngula]

Posted: Published on July 22nd, 2014

New genetic disorders pop up all the time each one represents a child who may face incredible challenges, or even be doomed to death. A child named Bertrand exhibited some serious symptoms profound developmental disabilities shortly after he was born, and no one could figure out what was wrong with him. So they took advantage of 21st century biotechnology and sequenced his genome, and the genome of both of his parents, and asked what novel mutations the child carried. For years, sequencing was too expensive for common usein 2001, the cost of sequencing a single human genome was around a hundred million dollars. But by 2010, with the advent of new technologies, that figure had dropped by more than ninety-nine per cent, to roughly fifty thousand dollars. To reduce costs further, the Duke researchers, including Shashi and a geneticist named David Goldstein, planned to sequence only the exomethe less than two per cent of the genome that codes for proteins and gives rise to the vast majority of known genetic disorders. In a handful of isolated cases, exome sequencing had been successfully used by doctors desperate to identify the causes of mysterious, life-threatening conditions. If the technique could be shown … Continue reading

Posted in Biology | Comments Off on Biology is a hard problem [Pharyngula]

Using synthetic biology to make new antibiotics

Posted: Published on July 22nd, 2014

Using synthetic biology to make new antibiotics Research at Victoria University of Wellington could lead to a new generation of antibiotics, helping tackle the global issue of superbugs that are resistant to modern medicine. Led by Mark Calcott, who has just completed his PhD study, under the supervision of Dr David Ackerley, an associate professor in the School of Biological Science, the research is delivering new knowledge about how synthetic biology might be used to counter bacteria that have become resistant to existing antibiotics. The recently published study defines new ways that microbes, which are used to make some commonly used types of antibiotics, can be reengineered to produce modified forms of the original molecules. Part of the problem is that people have historically been careless when using antibiotics, which has, one-by-one, allowed bacteria to build resistance, thrive and multiply. Were smarter now, but at a time when were running out of options, says Dr Ackerley. There is a serious and immediate need for new antibioticseither we have to develop the next generation or find clever and affordable ways of modifying the ones we currently have, he says. The basis of our research is the idea that the microbial machinery … Continue reading

Posted in Biology | Comments Off on Using synthetic biology to make new antibiotics

Page 3,888«..1020..3,8873,8883,8893,890..3,9003,910..»